Compounds > rofecoxib
Page last updated: 2024-11-04

rofecoxib and Aldosteronism

rofecoxib has been researched along with Aldosteronism in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism."1.31Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. ( Farfel, Z; Gurevitz, O; Mayan, H, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayan, H1
Gurevitz, O1
Farfel, Z1

Other Studies

1 other study available for rofecoxib and Aldosteronism

ArticleYear
Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
    Clinical nephrology, 2002, Volume: 58, Issue:1

    Topics: Adult; Alkalosis; Calcium; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism; Hypokalemia; Lacto

2002